Literature DB >> 25069758

[Analysis of type 2 diabetes-induced late effects based on administrative data of social insurance in Austria and implications for the evaluation of the DMP diabetes mellitus].

Franziska Großschädl1, Wolfgang Freidl, Willibald J Stronegger, Nathalie T Burkert, Johanna Muckenhuber, Éva Rásky.   

Abstract

The present study analyses administrative data of medical services related to the distribution of diabetes mellitus type 2-induced late effects. Pseudonymous statutory health insurance data of all Austrian social security institutions for the years 2006/2007 in outpatient and inpatient (performance and diagnostic data) setting were used. Type 2 diabetics have been identified by prescribed medication. The specific late effects were defined as endpoints and the respective diagnoses and health performances were extracted. The study population included 7,945,774 insured. The percentage of the defined late effects was significantly higher in diabetics than in persons from the general population, with exception for kidney transplantation. The risk of a late effect was greatest among diabetics for an amputation. The results of this study can be used as a baseline for the evaluation of DMP diabetes. The administrative data used are limited for answering the defined research questions. Anyway, the data quality must be improved and unified in Austria.

Entities:  

Mesh:

Year:  2014        PMID: 25069758     DOI: 10.1007/s10354-014-0291-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  23 in total

1.  Adoption of disease management model for diabetes in region of Maastricht.

Authors:  H J Vrijhoef; C Spreeuwenberg; I M Eijkelberg; B H Wolffenbuttel; G G van Merode
Journal:  BMJ       Date:  2001-10-27

2.  Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis.

Authors:  Anna Drabik; Guido Büscher; Karsten Thomas; Christian Graf; Dirk Müller; Stephanie Stock
Journal:  Popul Health Manag       Date:  2012-03-08       Impact factor: 2.459

3.  Long-term trends in obesity among Austrian adults and its relation with the social gradient: 1973-2007.

Authors:  Franziska Großschädl; Willibald J Stronegger
Journal:  Eur J Public Health       Date:  2012-04-25       Impact factor: 3.367

Review 4.  The genetic risk of kidney disease in type 2 diabetes.

Authors:  Marcus G Pezzolesi; Andrzej S Krolewski
Journal:  Med Clin North Am       Date:  2012-12-07       Impact factor: 5.456

5.  [Creation of a control group by matched pairs with GKV routine data for the evaluation of enrollment models].

Authors:  B Riens; B Broge; P Kaufmann-Kolle; B Pöhlmann; B Grün; D Ose; J Szecsenyi
Journal:  Gesundheitswesen       Date:  2010-05-04

Review 6.  Diabetes mellitus Type 2--the new face of an old lady.

Authors:  Katharina Timper; Marc Y Donath
Journal:  Swiss Med Wkly       Date:  2012-07-16       Impact factor: 2.193

7.  Amputations and diabetes: a case-control study.

Authors:  C Trautner; B Haastert; G Giani; M Berger
Journal:  Diabet Med       Date:  2002-01       Impact factor: 4.359

8.  [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].

Authors:  Antje Miksch; Johanna Trieschmann; Dominik Ose; Andreas Rölz; Marc Heiderhoff; Joachim Szecsenyi
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2010-07-21

9.  Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.

Authors:  Herwig Ostermann; Victoria Hoess; Michael Mueller
Journal:  BMC Public Health       Date:  2012-06-29       Impact factor: 3.295

10.  The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial.

Authors:  Andreas C Sönnichsen; Henrike Winkler; Maria Flamm; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser
Journal:  BMC Fam Pract       Date:  2010-11-05       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.